Overall rank by patents
#46,552
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Elevation Spine, Inc.
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
5
Total patents granted
2
CPC technology areas
20.4
Avg claims per patent
-
5-year filing velocity
The verdict
Elevation holds 5 US patents across 2 technology areas, rank #46,552 of 50,000 tracked assignees.
- #46,552
- of 50,000 US assignees by volume
- Top 56%
- by Innovation Score (33.4/100)
- 20.4
- avg claims per patent
Portfolio overview
Elevation Spine, Inc. has been granted 5 US utility patents between 2020 and 2024, placing Elevation Spine, Inc. at rank #46,552 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.4 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Elevation Spine, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Elevation sits between Elementum 3D, Inc. (5 patents, rank #46,548) and Elixirgen Therapeutics, Inc. (5 patents, rank #46,556) - the closest US assignees by grant volume. The composite Innovation Score of 33.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Elevation Spine, Inc.'s 20.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Elevation Spine, Inc. against peers pursuing similar technology classes.
Who files at Elevation's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Elementum 3D
Elementum 3D, Inc.
5 patents
- Elementum
Elementum Ltd
5 patents
- Elenco
Elenco Electronics, LLC
5 patents
- Elevate
Elevate Technologies LLC
5 patents
- Elexopharm
ElexoPharm GmbH
5 patents
- Eligible
Eligible, Inc.
5 patents
- Elite Robotics
Elite Robotics
5 patents
- Elixirgen Therape…
Elixirgen Therapeutics, Inc.
5 patents
- Elevation Spine ◀
Elevation Spine, Inc.
5 patents
What this shows Elevation holds 5 patents at rank #46,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Elevation
By rank, the assignees closest to #46,552 in granted patent volume.
- Elementum 3D, Inc. #46,548 · 5 patents
- Elementum Ltd #46,549 · 5 patents
- Elenco Electronics, Llc #46,550 · 5 patents
- Elevate Technologies Llc #46,551 · 5 patents
- Elexopharm Gmbh #46,553 · 5 patents
- Eligible, Inc. #46,554 · 5 patents
- Elite Robotics #46,555 · 5 patents
- Elixirgen Therapeutics, Inc. #46,556 · 5 patents
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Elevation's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Elevation's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 56% higher than 44% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Which technologies does Elevation Spine, Inc. patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Frequently Asked Questions
How many patents does Elevation Spine, Inc. hold?
Elevation Spine, Inc. holds 5 US granted patents filed between 2020 and 2024, spanning 2 technology areas.
What is Elevation Spine, Inc.'s Innovation Score?
Elevation Spine, Inc. has an Innovation Score of 33.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Elevation Spine, Inc. focus on?
Elevation Spine, Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 5 patents. The company has filed patents in 2 CPC subclasses total.
Is Elevation Spine, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Elevation Spine, Inc..
What does claim depth mean for Elevation Spine, Inc.'s patents?
Elevation Spine, Inc.'s patents average 20.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Elevation Spine, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Elevation's 5 grants land it in the top 56% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Elevation ranks #46,552 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.